Imunon, Inc. (IMNN)
0.6231
-0.01
(-0.94%)
USD |
NASDAQ |
Nov 16, 13:48
Imunon Total Liabilities (Quarterly) : 9.386M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 9.386M |
| June 30, 2026 | 10.80M |
| March 31, 2026 | 4.659M |
| December 31, 2025 | 5.226M |
| September 30, 2025 | 4.906M |
| June 30, 2025 | 6.128M |
| March 31, 2025 | 6.410M |
| December 31, 2024 | 5.473M |
| September 30, 2024 | 6.200M |
| June 30, 2024 | 5.950M |
| March 31, 2024 | 5.825M |
| December 31, 2023 | 8.530M |
| September 30, 2023 | 6.583M |
| June 30, 2023 | 7.207M |
| March 31, 2023 | 15.46M |
| December 31, 2022 | 14.65M |
| September 30, 2022 | 19.18M |
| June 30, 2022 | 18.29M |
| March 31, 2022 | 18.08M |
| December 31, 2021 | 18.25M |
| September 30, 2021 | 20.13M |
| June 30, 2021 | 18.96M |
| March 31, 2021 | 18.08M |
| December 31, 2020 | 18.92M |
| September 30, 2020 | 18.62M |
| Date | Value |
|---|---|
| June 30, 2020 | 22.51M |
| March 31, 2020 | 22.73M |
| December 31, 2019 | 23.72M |
| September 30, 2019 | 25.10M |
| June 30, 2019 | 24.76M |
| March 31, 2019 | 24.00M |
| December 31, 2018 | 25.99M |
| September 30, 2018 | 25.78M |
| June 30, 2018 | 30.36M |
| March 31, 2018 | 20.39M |
| December 31, 2017 | 20.81M |
| September 30, 2017 | 20.71M |
| June 30, 2017 | 23.01M |
| March 31, 2017 | 24.69M |
| December 31, 2016 | 24.12M |
| September 30, 2016 | 26.89M |
| June 30, 2016 | 27.00M |
| March 31, 2016 | 28.02M |
| December 31, 2015 | 28.64M |
| September 30, 2015 | 28.58M |
| June 30, 2015 | 31.31M |
| March 31, 2015 | 33.08M |
| December 31, 2014 | 33.87M |
| September 30, 2014 | 34.66M |
| June 30, 2014 | 34.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 52.08M |
| Taysha Gene Therapies, Inc. | 78.06M |
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.01M |
| Shareholders Equity (Quarterly) | 2.622M |
| Debt to Equity Ratio | 2.646 |
| Current Ratio | 1.377 |
| Net Debt Paydown Yield | -14.34% |